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each participant was randomly assigned to a pla‑
cebo or ED group using an internet random num‑
ber generator (www.random.org). At the begin‑
ning of each meeting, participants were asked 
to drink 500 ml of the Rockstar Xdurance Trop‑
ical Orange (PepsiCo, Harrison, New York, Unit‑
ed States) in 5 minutes. The beverage contained 
160 mg of caffeine, 2000 mg of taurine, 50 mg 
of guarana, 75 mg of carbohydrate, and 0.15 g of 
sodium. Total energy of the drink was 320 kcal. 
The placebo, that is, Mirinda (PepsiCo, Harrison, 
New York, United States), did not differ in color, 
smell, taste, nor temperature. It contained 64.5 g 
of carbohydrate and less than 0.01 g of sodium 
with 240 kcal of total energy. Beverage drinking 
was witnessed by one of the investigators. Drinks 
were purchased from the funds of the Students’ 
Scientific Group. Participants underwent 4 non‑
invasive examinations before and after drink 
consumption. For each person, all procedures 
were performed in the same sequence and time 
intervals. Peripheral blood pressure (BP) and 
heart rate (HR) were measured 15, 30, and 75 
minutes from baseline with a standard calibrated 
automated device, the Omron M3 (Omron, Kyo‑
to, Japan). A 12‑lead electrocardiogram was per‑
formed 30 minutes from baseline. All echocar‑
diographic measurements were performed by one 
experienced observer using a digital ultrasound 
Introduction Energy drinks (ED) contain var‑
ious substances that act as stimulants: caffeine, 
taurine, guarana, and ginseng.1 They are adver‑
tised as mental and physical stimulants and their 
consumption have increased significantly over 
the past years.1 Cardiovascular adverse effects 
of EDs have been reported,2 but their impact on 
heart function is still not fully known. Therefore, 
our aim was to investigate the influence of a sin‑
gle dosage of an ED on acute hemodynamic pa‑
rameters in young volunteers.
Methods We included volunteers aged between 
18 and 30 years, exclusion criteria were: arterial 
hypertension and other cardiovascular diseases, 
body weight less than 50 kg, diabetes, thyroid 
diseases, consumption of more than 250 ml of 
EDs a week or more than 3 coffees a day, history 
of caffeine sensitivity or allergy, and pregnancy or 
breastfeeding. The study was performed from De‑
cember 2016 to January 2017. All volunteers re‑
ceived comprehensive information about the out‑
line of the experiment and gave written consent 
to participate. The study was approved by the Bio‑
ethics Committee of Jagiellonian University. We 
conducted a randomized double ‑blind placebo‑
‑controlled crossover study. Each participant at‑
tended 2 experimental sessions with a 2 weeks 
washout period in between. At the first meeting, 
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The t test for paired data was applied for mea‑
sures where each participant was its own con‑
trol, while the unpaired t test was used to com‑
pare baseline results. P value of less than 0.05 
was considered significant.
Results and discussion A total of 18 healthy 
young people were included in the study (fe‑
male sex, 39%; mean [SD] age, 23.67 [1.19] years; 
mean [SD] body mass index, 24.67 (3.54) kg/m2; 
smokers, 11%). Full results of the study are pre‑
sented in Supplementary material, Table S1. We 
observed a significant increase in BP 75 min‑
utes after consumption of a single dose of an ED 
compared with placebo (5.67 vs –0.33 mm Hg, 
respectively; P = 0.03) and increase in dia‑
stolic BP 15 minutes after its consumption 
(4.78 vs –1.56 mm Hg, respectively; P = 0.03) 
(FIGURE 1A and 1B). No significant changes in HR and 
electrocardiographic parameters were found. 
Our findings are similar to that of another study 
(n = 25), which used an ED in comparable volume 
and composition (240 mg of caffeine, 2000 mg 
of taurine) and observed significant 6.6 mm Hg 
elevation of systolic BP compared with place‑
bo, with no effect on HR.4 Further, Phan et al5 
found a significant increase in central systolic 
BP 3 hours after consumption of an ED, while 
Fletcher et al6 observed only elevation in pe‑
ripheral BP and did not detect differences in 
any parameters of central BP measurements. 
In a study by Szotowska et al,7 diastolic BP and 
HR increased only after a larger dose of an ED 
(360 mg of caffeine), while for the dose compara‑
ble with that used in our experiment (120 mg of 
caffeine) no change was observed. Discrepancies 
in results of previous studies on hemodynam‑
ic effects of energy drinks may be explained by 
differences in volume and composition of bev‑
erages (mainly caffeine amount), and the time 
interval between the ED consumption and BP 
measurements.
Mechanism of the influence of EDs on BP is 
not clear, and the most widely accepted hypoth‑
esis is the activation of the catecholamine path‑
way.4 However, in the available literature, there 
is no information regarding the hemodynam‑
ic profile of the ingredients contained in EDs.
In our study, EDs did not affect any of 
the echocardiographic parameters, including 
those analyzed with speckle ‑tracking echo‑
cardiography technique. In a open ‑label study 
by Menci et al,8 ED consumption was followed 
by a significant increase in cardiac performance.
Due to the fact that BP is determined by 
the total peripheral resistance and cardiac out‑
put, and the latter is determined by HR and 
stroke volume, which did not change signifi‑
cantly in our experiment, we hypothesized that 
the increase in BP was caused by changes in vas‑
cular properties. Although not significant, we 
observed a trend towards the elevation of PWV 
system equipped with a 3.5 MHz transducer (GE 
Vivid 7, General Electric Vingmed Ultrasound, 
Horten, Norway). At least 3 cardiac cycles were 
recorded and digitally stored for offline analysis. 
One experienced observer analyzed the conven‑
tional echocardiographic images, using a work 
station running the EchoPac software version 
BT11.0.0 (GE Vingmed). The measurement of 
carotid ‑femoral pulse wave velocity (PWV) was 
performed with the use of the SphygmoCor sys‑
tem (Model MM3, software version 6.31; AtCor 
Medical, Sydney, Australia). Arterial waveforms 
were obtained with the high ‑fidelity SPC‑301 mi‑
cromanometer (Millar Instruments, Inc., Hous‑
ton, Texas, United States) interfaced with a com‑
puter running the SphygmoCor software. Arteri‑
al PWV was determined by the foot ‑to ‑foot flow 
wave velocity method.3
Statistical analysis Data were analyzed with 
the STATISTICA 12 PL software (StatSoft, Tul‑
sa, Oklahoma, United States). Data distribution 
was gaussian. Continuous variables were shown 
as a mean (SD).
FIGURE 1 Changes in systolic (A) and diastolic (B) blood pressure in 3 time intervals after the 
consumption of an energy drink or placebo 
Abbreviations: DBP, diastolic blood pressure; SBP, systolic blood pressure
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post ED consumption (P = 0.09). Pulse wave ve‑
locity is the index of vascular elasticity. Dynam‑
ic changes of this parameter may reflect periph‑
eral vascular sympathetic function.9 Pulse wave 
velocity is also an independent risk factor of car‑
diovascular disease as shown in Polish patients.10 
Changes in BP an PWV may reflect an increase 
in vascular resistance induced by sympathetic 
modulation after ED consumption; however, our 
study with limited number of participants does 
not allow to draw such a conclusion. Neverthe‑
less, to our knowledge, this is the first study ex‑
amining the influence of EDs on PWV. Further 
studies are needed to elucidate the role of en‑
dothelial function and autonomic modulation 
in ED ‑mediated BP elevation.
In conclusion, our pilot study suggests that 
a single dose of an ED increases peripheral 
BP—both systolic and diastolic—and does not 
affect HR, central BP, nor cardiac performance. 
While the increase in BP in our study was mild 
and would not raise concerns in an acute set‑
ting, the sustained elevation of BP at the popu‑
lation level is proven to increase the risk of ad‑
verse cardiovascular outcomes.11 As there are 
only few studies on this topic, further investi‑
gations are needed to reveal the effect of EDs on 
BP and vascular function.
SUPPLEMENTARY MATERIAL 
Supplementary material is available at www.mp.pl/kardiologiapolska.
ARTICLE INFORMATION
CONFLICT OF INTEREST None declared.
OPEN ACCESS This is an Open Access article distributed under the terms 
of the Creative Commons Attribution -NonCommercial -NoDerivatives 4.0 In-
ternational License (CC BY -NC -ND 4.0), allowing third parties to download ar-
ticles and share them with others, provided the original work is properly cited, 
not changed in any way, distributed under the same license, and used for non-
commercial purposes only. For commercial use, please contact the journal office 
at kardiologiapolska@ptkardio.pl.
HOW TO CITE Stopa M, Łobacz M, Niemczyk M, et al. Influence of energy 
drinks on acute hemodynamic parameters in young healthy adults: a random-
ized double -blind placebo -controlled cross -over pilot study. Kardiol Pol. 2020; 78: 
335-337. doi:10.33963/KP.15231
REFERENCES
1 Reissig CJ, Strain EC, Griffiths RR. Caffeinated energy drinks - a growing prob-
lem. Drug Alcohol Depend. 2009; 99: 1-10.
2 Clauson KA, Shields KM, McQueen CE, Persad N. Safety issues associated with 
commercially available energy drinks. J Am Pharm Assoc. 2008; 48: 55-67.
3 Wojciechowska W, Staessen JA, Nawrot T, et al. Reference values in white Eu-
ropeans for the arterial pulse wave recorded by means of the SphygmoCor device. 
Hypertens Res. 2006; 29: 475-483.
4 Svatikova A, Covassin N, Somers KR, et al. A randomized trial of cardiovascu-
lar responses to energy drink consumption in healthy adults. JAMA. 2015; 314: 
2079-2082.
5 Phan JK, Shah SA. Effect of caffeinated versus noncaffeinated energy drinks on 
central blood pressures. Pharmacotherapy. 2014; 34: 555-560.
6 Fletcher EA, Lacey CS, Aaron M, et al. Randomized controlled trial of high-
-volume energy drink versus caffeine consumption on ECG and hemodynamic pa-
rameters. J Am Heart Assoc. 2017; 6: e004448.
7 Szotowska M, Bartmańska M, Wyskida K, et al. The influence of so called „en-
ergy drinks” on the blood pressure and the pulse rate in young, healthy adults. Ar-
ter Hypertens. 2013; 17: 169-174.
8 Menci D, Righini FM, Cameli M, et al. Acute effects of an energy drink on myo-
cardial function assessed by conventional echo -Doppler analysis and by speckle 
tracking echocardiography on young healthy subjects. J Amino Acids. 2013; 2 013: 
646703.
